Clinical Trial Update: AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nimotuzumab with irreversible electroporation ablation for locally advanced pancreatic cancer; the study is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Pancreatic Cancer, Adult | Phase 2 | Status: NOT_YET_RECRUITING